Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of Directors

          Phio Pharmaceuticals Announces Appointment of David H. Deming to Board of DirectorsFebruary 20, 2025 7:45 AM EST | Source: Phio Pharmaceuticals Corp.Marlborough, Massachusetts--(Newsfile Corp. - February 20, 2025) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage biotechnology company developing therapeutics that use its INTASYL® siRNA gene silencing technology designed to make the body's immune cells more effective in killing cancer cells. Phio announced today the appointment of ...